Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
123I-Iodometomidate for Adrenal Scintigraphy
NCT00454103Phase 2Completed
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 123I-iodometomidate in adrenal tumor, adrenocortical carcinoma (ACC). Started Mar 2007; status: completed.
02
Drugs
123I-iodometomidate
03
Conditions
adrenal tumoradrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00454103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454103.